|
|
|
| home > white papers > Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor - Eppendorf |
|
|
 WHITE PAPERS |
|
Eppendorf
|
|
Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor
|
|
The number of bioprocess applications for microalgae has increased in
recent years, particularly in the fi eld of biofuel production. The
combination of the New Brunswick CelliGen 310 stirred-tank bioreactor
and the DASGIP LED Illumination System creates a bioreactor setup which
is capable of supporting high density microalgal growth. Using the
stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and
intensities can be controlled for optimal support of all types of
chlorophylls and carotenoids. For this study in which high density
culture of up to 1.5 x 107 cells/mL was achieved, the unicellular
freshwater alga, Dunaliella tertiolecta, was used.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
uMotif Announces First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones
Patent-protected Motif data capture interface proven as equivalent
method to capture Patient Reported Outcome and eDiary data, eliminates
reliance on text-based instruments, in study with 55 participants in 2
randomized groups conducted by SAFIRA Clinical Research at Dublin City
University
More info >> |
|
 |
White Papers |
 |
|
Is Your Biobank Ready for the Challenge of Biomarker-based Research?
BioFortis
Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems. Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >> |
|
|
|
